GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avacta Group PLC (LSE:AVCT) » Definitions » EV-to-EBIT

Avacta Group (LSE:AVCT) EV-to-EBIT : -13.17 (As of May. 16, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Avacta Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Avacta Group's Enterprise Value is £165.76 Mil. Avacta Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-12.59 Mil. Therefore, Avacta Group's EV-to-EBIT for today is -13.17.

The historical rank and industry rank for Avacta Group's EV-to-EBIT or its related term are showing as below:

LSE:AVCT' s EV-to-EBIT Range Over the Past 10 Years
Min: -30.36   Med: -8.48   Max: -0.51
Current: -13.18

During the past 13 years, the highest EV-to-EBIT of Avacta Group was -0.51. The lowest was -30.36. And the median was -8.48.

LSE:AVCT's EV-to-EBIT is ranked worse than
100% of 429 companies
in the Biotechnology industry
Industry Median: 9.84 vs LSE:AVCT: -13.18

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Avacta Group's Enterprise Value for the quarter that ended in Dec. 2023 was £342.74 Mil. Avacta Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-12.59 Mil. Avacta Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -3.67%.


Avacta Group EV-to-EBIT Historical Data

The historical data trend for Avacta Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avacta Group EV-to-EBIT Chart

Avacta Group Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.14 -12.90 -10.16 -7.38 -27.23

Avacta Group Semi-Annual Data
Jul13 Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.16 - -7.38 - -27.23

Competitive Comparison of Avacta Group's EV-to-EBIT

For the Biotechnology subindustry, Avacta Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avacta Group's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avacta Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Avacta Group's EV-to-EBIT falls into.



Avacta Group EV-to-EBIT Calculation

Avacta Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=165.762/-12.587
=-13.17

Avacta Group's current Enterprise Value is £165.76 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Avacta Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-12.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avacta Group  (LSE:AVCT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Avacta Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-12.587/342.73919
=-3.67 %

Avacta Group's Enterprise Value for the quarter that ended in Dec. 2023 was £342.74 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Avacta Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-12.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avacta Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Avacta Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Avacta Group (LSE:AVCT) Business Description

Traded in Other Exchanges
Address
Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, GBR, LS23 7FA
Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.

Avacta Group (LSE:AVCT) Headlines

No Headlines